好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2005 Annual Meeting | Chronic Daily and Medication Overuse Headache: Prognosis and Treatment

Thursday 04/14/05
03:45 PM - 05:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Headache and Pain
No CME available
Event Timeline
03:45 PM - 05:00 PM Abstract 001 - Body Mass Index and Headache: Associations with Attack Frequency, Severity and Disability
03:45 PM - 05:00 PM Abstract 002 - Botulinum Toxin Type a for the Prophylactic Treatment of Chronic Daily Headache: A Randomized, Double-Blind, Placebo-Controlled Trial
03:45 PM - 05:00 PM Abstract 003 - Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache: Subgroup Analysis of Patients Not Receiving Other Prophylactic Medications (A Randomized Double-Blind, Placebo-Controlled Study)
03:45 PM - 05:00 PM Abstract 004 - Effect of CPAP Therapy on Pain, Disability and Quality of Life in Chronic Daily Headache and Sleep Apnea: A Randomized Controlled Trial
03:45 PM - 05:00 PM Abstract 005 - Prednisone in the Treatment of Medication Withdrawal Headache Following Medication Overuse Headache: A Placebo-Controlled, Double-Blind and Randomized Pilot Study
Faculty Disclosures
Thomas N. Ward, MD, FAAN No disclosure on file
Joel R. Saper, MD, FAAN No disclosure on file
Martha Morrell, MD, FAAN Dr. Morrell has received personal compensation for serving as an employee of NeuroPace. Dr. Morrell has stock in NeuroPace. The institution of Dr. Morrell has received research support from National Institutes of Health.
Dileep R. Nair, MD Dr. Nair has nothing to disclose.
Stephen Hantus, MD Dr. Hantus has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Hantus has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB.
Rouzbeh Fateh, MD No disclosure on file
Farrah J. Mateen, MD, PhD, FAAN Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics (Amgen). Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from EMD Serono. The institution of Dr. Mateen has received research support from Novartis. The institution of Dr. Mateen has received research support from Horizon Therapeutics (Amgen). The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care.
No disclosure on file
Claude Steriade, MD The institution of Dr. Steriade has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for The Epilepsy Study Consortium. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Steriade has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for DOJ. The institution of Dr. Steriade has received research support from NIH. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Epitel. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Jazz Pharmaceuticals.
John W. Lindsey, MD Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Banner Life Sciences. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Lindsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mapi. Dr. Lindsey has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Teva. The institution of Dr. Lindsey has received research support from Genentech.
Alex D. Rae-Grant, MD, FAAN Dr. Rae-Grant has received publishing royalties from a publication relating to health care. Dr. Rae-Grant has received publishing royalties from a publication relating to health care.
Lan Tan No disclosure on file
Jae Hyun Park, MD No disclosure on file
Jun Hong Lee, MD No disclosure on file
Sung-Hee Hwang No disclosure on file
Rocio Vazquez Do Campo, MD Dr. Vazquez Do Campo has nothing to disclose.
Hongki Song No disclosure on file
Jin-Tai Yu No disclosure on file
Erick N. Viorritto, MD, MPH No disclosure on file
Hammad A. Bokhari, DO Dr. Bokhari has nothing to disclose.
Lin Tan No disclosure on file
Erik Strauss, MD No disclosure on file